These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):7033-41. PubMed ID: 16203797 [Abstract] [Full Text] [Related]
4. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Fang MZ, Jin Z, Wang Y, Liao J, Yang GY, Wang LD, Yang CS. Int J Oncol; 2005 Mar 01; 26(3):615-22. PubMed ID: 15703815 [Abstract] [Full Text] [Related]
6. Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells. Morris J, Moseley VR, Cabang AB, Coleman K, Wei W, Garrett-Mayer E, Wargovich MJ. Oncotarget; 2016 Jun 07; 7(23):35313-26. PubMed ID: 27167203 [Abstract] [Full Text] [Related]
7. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Cui X, Wakai T, Shirai Y, Yokoyama N, Hatakeyama K, Hirano S. Hum Pathol; 2006 Mar 07; 37(3):298-311. PubMed ID: 16613325 [Abstract] [Full Text] [Related]
9. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Lee WJ, Shim JY, Zhu BT. Mol Pharmacol; 2005 Oct 07; 68(4):1018-30. PubMed ID: 16037419 [Abstract] [Full Text] [Related]
12. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression. Gu B, Ding Q, Xia G, Fang Z. Oncol Rep; 2009 Mar 07; 21(3):635-40. PubMed ID: 19212621 [Abstract] [Full Text] [Related]
13. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Viswanathan M, Tsuchida N, Shanmugam G. Int J Cancer; 2003 May 20; 105(1):41-6. PubMed ID: 12672028 [Abstract] [Full Text] [Related]
14. The Inhibitory Effect of (-)-Epigallocatechin-3-Gallate on Breast Cancer Progression via Reducing SCUBE2 Methylation and DNMT Activity. Sheng J, Shi W, Guo H, Long W, Wang Y, Qi J, Liu J, Xu Y. Molecules; 2019 Aug 09; 24(16):. PubMed ID: 31404982 [Abstract] [Full Text] [Related]
15. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa. Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W. Pathobiology; 2001 Aug 09; 69(3):143-9. PubMed ID: 11872960 [Abstract] [Full Text] [Related]
16. Gene methylation in gastric cancer. Qu Y, Dang S, Hou P. Clin Chim Acta; 2013 Sep 23; 424():53-65. PubMed ID: 23669186 [Abstract] [Full Text] [Related]
17. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Ye C, Shrubsole MJ, Cai Q, Ness R, Grady WM, Smalley W, Cai H, Washington K, Zheng W. Oncol Rep; 2006 Aug 23; 16(2):429-35. PubMed ID: 16820927 [Abstract] [Full Text] [Related]
18. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma. Wang Y, Fang MZ, Liao J, Yang GY, Nie Y, Song Y, So C, Xu X, Wang LD, Yang CS. Clin Cancer Res; 2003 Nov 01; 9(14):5257-63. PubMed ID: 14614007 [Abstract] [Full Text] [Related]
19. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Guo M, Ren J, House MG, Qi Y, Brock MV, Herman JG. Clin Cancer Res; 2006 Aug 01; 12(15):4515-22. PubMed ID: 16899597 [Abstract] [Full Text] [Related]
20. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer. Fox EJ, Leahy DT, Geraghty R, Mulcahy HE, Fennelly D, Hyland JM, O'Donoghue DP, Sheahan K. J Mol Diagn; 2006 Feb 01; 8(1):68-75. PubMed ID: 16436636 [Abstract] [Full Text] [Related] Page: [Next] [New Search]